Psychiatry and Neurology, Neurology · Escondido, CA
NPI
1386890770
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1955 Citracado Pkwy Ste 102
Escondido, CA, 92029
Phone (760) 631-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
4,333 services
Medicare patients, 2024
347
Average age 70
Drug cost, 2024
$749K
1,805 prescriptions
Company payments, 2025
$2,919
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chunyang T Wang was code J0585 (injection, onabotulinumtoxina, 1 unit), 3,400 times for 11 patients. In total Chunyang T Wang billed 4,333 services in 47 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 3,400 | 11 | $4.84 | $16K |
| 99215 Office E&M - Established | Office | 155 | 105 | $141.91 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 131 | 93 | $13.47 | $1,765 |
| 99214 Office E&M - Established | Office | 113 | 88 | $89.60 | $10K |
| 95886 Electrical Nerve Conductivity | Office | 73 | 50 | $84.52 | $6,170 |
| 99205 Office E&M - New | Office | 53 | 53 | $165.67 | $8,781 |
| 95708 Neurologic | Office | 51 | 38 | $256.16 | $13K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 48 | 36 | $26.13 | $1,254 |
| 95816 Neurologic | Office | 41 | 41 | $357.66 | $15K |
| 95700 Neurologic | Office | 39 | 38 | $231.65 | $9,034 |
| 95719 Neurologic | Office | 32 | 31 | $132.91 | $4,253 |
| 95816 Neurologic | Facility | 31 | 30 | $43.34 | $1,343 |
| 64615 Musculoskeletal | Office | 17 | 11 | $125.45 | $2,133 |
| 95910 Electrical Nerve Conductivity | Office | 16 | 16 | $140.53 | $2,248 |
| 95908 Electrical Nerve Conductivity | Office | 13 | 13 | $96.41 | $1,253 |
By year: 2022 $125K for 3,183 services; 2023 $128K for 4,077 services; 2024 $129K for 4,333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chunyang T Wang prescribed most often to Medicare patients was Lamotrigine, with 278 prescriptions and refills. In total Chunyang T Wang wrote 1,805 Medicare prescriptions that cost $749K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 278 | 430 | 46 | $3,611 |
| Levetiracetam Generic | 197 | 363 | 42 | $6,296 |
| Gabapentin Generic | 155 | 191 | 40 | $1,994 |
| Lacosamide Generic | 143 | 183 | 30 | $16K |
| Topiramate Er Topiramate | 87 | 106 | Under 11 | $89K |
| Aptiom Eslicarbazepine Acetate | 87 | 87 | Under 11 | $199K |
| Levetiracetam Er Levetiracetam | 71 | 171 | 17 | $3,202 |
| Divalproex Sodium Er Divalproex Sodium | 68 | 75 | Under 11 | $2,326 |
| Lamotrigine Er Lamotrigine | 61 | 77 | Under 11 | $13K |
| Briviact Brivaracetam | 54 | 56 | Under 11 | $81K |
| Memantine Hcl Generic | 46 | 72 | Under 11 | $6,382 |
| Topiramate Generic | 43 | 49 | Under 11 | $531 |
| Divalproex Sodium Generic | 41 | 57 | Under 11 | $1,588 |
| Memantine Hcl Er Memantine Hcl | 31 | 39 | Under 11 | $1,343 |
| Citalopram Hbr Citalopram Hydrobromide | 25 | 35 | Under 11 | $145 |
Brand drugs: - claims; generic drugs: 1,494 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chunyang T Wang $2,919 ($2,919 in general payments such as food, travel and fees) from 22 companies. The largest payer was UCB, Inc. with $1,030.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 32 | $1,030 |
| Lundbeck LLC | 21 | $358 |
| Lilly USA, LLC LLY | 7 | $220 |
| ACADIA Pharmaceuticals Inc ACAD | 4 | $213 |
| Neurelis, Inc. | 11 | $203 |
| SK Life Science, Inc. | 17 | $184 |
| Corcept Therapeutics CORT | 1 | $104 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $96.32 |
| Philips North America LLC PHG | 2 | $76.86 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $65.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.